Skip to main content
. 2022 Dec 2;38(10):657–663. doi: 10.1089/jop.2022.0069

Table 2.

Visual Function and Corneal Health Status Questionnaire

  Netarsudil QD (n = 20) Netarsudil BID (n = 20)
Visual Acuity Factor Score, mean ± SEM
 Baseline score 1.07 ± 0.1 0.67 ± 0.15
 Change from baseline
  Week 4 −0.39 ± 0.13 (P = 0.0058)* −0.14 ± 0.12 (P = 0.2252)
  Week 8 −0.34 ± 0.12 (P = 0.0121)* −0.24 ± 0.13 (P = 0.0407)*
Glare Factor and Diurnal Variation Score, mean ± SEM
 Baseline score 0.72 ± 0.09 0.38 ± 0.12
 Change from baseline
  Week 4 −0.28 ± 0.11 (P = 0.0148)* 0.04 ± 0.08 (P = 0.6300)
  Week 8 −0.29 ± 0.11 (P = 0.0200)* −0.02 ± 0.10 (P = 0.9472)
*

Statistically significant at 5% level. P values based on one-sample t-test for within-group comparisons to baseline.

SEM, standard error of mean.